Medicine and Dentistry
Polypeptide
100%
Breast Cancer
62%
Gemcitabine
50%
Single Nucleotide Polymorphism
50%
Haplotype
37%
Peripheral Blood Mononuclear Cell
25%
Neutropenia
25%
Deoxycytidine Phosphate Deaminase
25%
Deoxycytidine Kinase
25%
Metabolism
12%
Drug Toxicity
12%
Toxicity
12%
Genomic DNA
12%
Breast Cancer Cell Line
12%
Monotherapy
12%
Drug Response
12%
Pharmacology, Toxicology and Pharmaceutical Science
Polypeptide
100%
Ribonucleotide Reductase
100%
Breast Cancer
62%
Gemcitabine
50%
Neutropenia
25%
Deoxycytidine Kinase
25%
Deoxycytidine Phosphate Deaminase
25%
Toxicity
12%
Normal Human
12%
Genomic DNA
12%
Monotherapy
12%
Agricultural and Biological Sciences
Polypeptide
100%
Ribonucleotide Reductase
100%
Single Nucleotide Polymorphism
50%
Haplotype
37%
Peripheral Blood Mononuclear Cell
25%
Deoxycytidine Kinase
25%
Cell Lines
12%
Toxicity
12%
Genomic DNA
12%
Metabolism
12%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
50%
Gemcitabine
50%
Haplotype
37%
Deoxycytidine
25%
Peripheral Blood Mononuclear Cell
25%
Deoxycytidine Kinase
25%
Cancer Cell
12%
Nested Gene
12%
Normal Human
12%
Metabolic Pathway
12%
Drug Response
12%
Drug Toxicity
12%